Why do we need to make health technology assessment (HTA) more realistic? Is HTA not realistic nowadays? The answers can be both YES and NO.HTA is a form of research for synthesising data to evaluate properties, effects, and impacts of health interventions and technology in diffe

Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in

The Health Intervention and Technology Assessment Program (HITAP), a member of the International Decision Support Initiative (iDSI) organised a side meeting titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Universal Health Coverage Dialogue” at the Prince Mahidol Award

Usa Chaikledkaew BSc(Pharm), MA, PhD*,** * Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand ** Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thail

The Health Technology Assessment (HTA), which is a crucial tool for setting health intervention priorities, has been rapidly developing in Asia-Pacific, but is still not fully employed by many countries in policy decision making. Although HTA institutions and networks have been operating successfully in OECD countries and a few of the middle-income

With Universal Health Coverage (UHC) high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in the scale-up of essential health services to meet the needs of their people. This has led to the recognition of health te

PMAC 2016 Side Event (SE 026): Making decision makers accountable: better journalism – better chances of getting to Universal Health CoverageThis workshop will bring together journalists, bloggers and editors from around the world to share stories of reporting countries’ journey towards and efforts

PMAC 2016 Side Event (SE 014): Advanced Workshop in Methods for HTAThe methods of HTA have developed rapidly in the last decade. This is particularly the case in assessing the cost-effectiveness of interventions using modelling methods and in undertaking uncertainty analysis to guide decisions. Deci

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces

During the PMAC 2015, a side meeting on the role of the international Decision Support Initiative (http://www.idsihealth.org/about-us/) was organized in order to discuss: progress of the initiative so far and the challenges of country-led reforms. To begin, NICE International gave a presentation on